Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache
Conditions: Stroke (CVA) or TIA; Headache, Migraine; Botulinum Toxins, Type A; Cerebral Venous Sinus Thrombosis; Carotid Dissection Artery; Vertebral Dissection Artery; Hemorrhagic Stroke; Reversible Cerebral Vasoconstriction Syndrome Interventions: Drug: Botox 200 UNT Injection; Combination Product: Non Botox based Standard of Care Treatments for Headache/Migraine Sponsor: University of Alberta Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials